Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. J of Skin [Internet]. 2020 Jan. 28 [cited 2025 Apr. 19];4(1):S12. Available from: https://skin.dermsquared.com/skin/article/view/826